Responsible and forward-looking corporate governance – taking into account both the expected returns of our investors and the Group’s long-term development – is a key concern for our Group.
Bentley Group’s governance bodies comprise the Management Board and the controlling, non-executive Board of Directors.
The Board of Directors consists of five members deeply rooted in the medtech industry. Annika Sunnanväder, daughter of co-founder and major shareholder Lars Sunnanväder, is the Chairperson of the Board of Directors and just as dedicated to the long-term development of the company as the founders.
Board of Directors
Chairperson
Years of experience in MedTech: 16 years
Biography:
• Co-CEO in LS MedCap, now taking over the baton as Chairperson of the Board in Bentley
• MBA from London Business School
• MSc in Cellular Biology, Genetics and Pharmacology from the University of Tübingen
Board of Directors
Member of the Board
Years of experience in MedTech: 50 years
Biography:
Founder and Board member of Bentley. Successfully founded, grew and exited several other ventures, such as:
• Joka Kathetertechnik GmbH (Intensive Care, sold to Gambro AB, 1993)
• Jomed AG (Interventional Cardiology, IPO on SWX, 2000)
• Jostra AG (Cardiac Surgery, sold to Getinge AB, 2003)
• Jolife AB (Resuscitation, sold to Physio- Control, Inc. 2011)
Board of Directors
Member of the Board
Years of experience in MedTech: 9 years
Biography:
• Board member of Bentley since December 2018
• Bachelor of Sales & Marketing from Sawi
• CFC en Gestionaire de commerce de détail from EPCN
Board of Directors
Member of the Board
Born: Germany
Education: BA International Marketing, Executive MBA (Donau University)
Background: +29 years experience from senior management positions at various MedTech companies including Maquet Cardiopulmonary, Heine Optotechnik and Carl Zeiss Meditec
Board of Directors
Member of the Board
Biography:
• Board member of Bentley as of October 2023
• James is a Partner at Keensight Capital.
• An Irish citizen, he holds an MBA from INSEAD, as well as a Medical Sciences degree and a degree in Medicine from the University of Nottingham.
• Prior to Keensight, he spent 7 years with H.I.G. Capital, where he was Head of Healthcare for Europe focused on proprietary deal flow across northern Europe.
• Prior to joining H.I.G. Capital, James was a Manager in the European Healthcare practice of Bain & Company.
• James started his career as a Medical Doctor in both London and Sydney, completing Plastics travelling fellowships in the Cook Islands, Belize and Guatemala. A Member of the Royal College of Surgeons, he was awarded the Preiskel Prize in Academic Surgery for Surgical research in developing countries.
The Group is managed by an experienced management team consisting of the CEO, CFO and CTO, featuring a compelling strategic and financial track record while developing Bentley from a start-up into one of the leading players in its market.
Management Board
CEO
Born: Germany
Education: BA International Marketing, Executive MBA (Donau University)
Background: +29 years experience from senior management positions at various MedTech companies including Maquet Cardiopulmonary, Heine Optotechnik and Carl Zeiss Meditec
Management Board
CFO
Born: UK
Education: BA Finance & Accounting (UK and Germany), MBA with Distinction (Manchester Business School)
Background: +20 years experience of leading the finance function in international environments.
12 years in international listed companies
Management Board
CTO
Born: Germany
Education: MSc. in Chemistry (Reutlingen University), Executive MBA (European School of Business)
Background: 14 years of experience in MedTech companies including Translumina
The company has an audit committee consisting of James Mitchell (Chair), Lars Sunnanväder and Eurico Pacheco. The tasks of the audit committee are set out in its instructions, which are adopted by the board of directors annually. The audit committee shall supervise the company’s financial reporting and the efficiency of the company’s internal control and risk management with reference to the financial reporting, be updated with reference to the audit of the annual report and other financial reports and examine and supervise the impartiality and the independency of the auditor.
The company has a remuneration committee consisting of Annika Sunnanväder (Chair), James Mitchell and Eurico Pacheco. The tasks of the remuneration committee are set out in its instructions, which are adopted by the board of directors annually. Its main task is to assist the board of directors in remuneration matters and submit proposals to ensure that compensation programs are designed to encourage high performance, promote accountability, and assure that employee interests are aligned with the interests of Bentley’s shareholders.